Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 811

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 811
---
under, including any applicable rules, regulations, guidelines, or other requirements of the
Regulatory Authorities that may be in effect from time to time.

1.6 “Biosimilar Product” means, with
respect to a Licensed Product and on a Region-by-Region basis in the Territory, a product that (a) is marketed for sale in such Region by a Third Party (not
directly or indirectly licensed, supplied or otherwise authorized by Aadi or any of its Affiliates or Sublicensees); and (b) has received Marketing Approval in such Region by means of an abbreviated procedure that relies in whole or in part on
the safety and efficacy data contained in the BLA or MAA for such Licensed Product submitted by or on behalf of Aadi or its Affiliate or Sublicensee in such Region to establish bioequivalence to such Licensed Product.

1.7 “Calendar Quarter” means the respective periods of three (3) consecutive calendar months ending on
March 31, June 30, September 30 or December 31, during the Term, or the applicable part thereof during the first or last calendar quarter of the Term.

1.8 “Calendar Year” means any year commencing on January 1 and ending on December 31, or the
applicable part thereof during the first or last year of the Term.

1.9 “Clinical Trial” means any human
clinical study or clinical trial of a Licensed Product.

1.10 “China” means the People’s Republic of
China, excluding, for purposes of this Agreement, Hong Kong, Macau, and Taiwan.

1.11 “Combination Product”
means a Licensed Product that is comprised of or contains one (1) or more Licensed ADCs as an active ingredient together with one (1) or more Other Active Ingredients, whether in the same or different formulations, so long as both the
Licensed ADC(s) and Other Active Ingredient(s) are sold as a single unit or for a single price.

1.12 “Commercialization” means any and all activities related to
pre-marketing, launching, marketing, promotion (including advertising and detailing), labeling, bidding and listing, pricing and reimbursement, distribution, storage, handling, offering for sale, selling,
having sold, importing, having imported, exporting, having exported, distributing, having distributed, providing customer service and support, conducting medical affairs, conducting post-marketing safety surveillance and reporting of or otherwise
commercializing Licensed ADCs and/or Licensed Products. “Commercial